Researchers at The University of Texas MD Anderson Cancer Center have found that a protein involved in immune response to microbes also can fuel cancer development and suppress immune response to the disease.
Dec 2, 2019
0
1666
Using a precursor to dendritic cells appears to be an efficient and effective way to stimulate the immune system to fight cancer tumors, according to a study in animal and cell models by researchers at the Duke Cancer Institute.
Nov 14, 2019
0
405
Researchers have discovered an immune control switch that could protect the brains of premature babies, who often suffer brain injuries when their immune response goes into overdrive.
Oct 30, 2019
0
102
Researchers have struggled for years to understand how mutations in one gene, called LRRK2, can increase the risk of three very different diseases: Parkinson's (a brain disease), Crohn's (a gut disease) and leprosy (a peripheral ...
Sep 25, 2019
0
479
A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.
Jun 6, 2019
0
135
A new animal model developed by Massachusetts General Hospital (MGH) investigators promises to be less expensive, easier to use and to improve personalized therapies for cancers and potentially other diseases. In their paper ...
Apr 25, 2019
0
40
Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.
Mar 9, 2019
1
354
New research by the University of Liverpool and Liverpool School of Tropical Medicine shows that vaccination with weakened strains of Salmonella may also protect against other infections.
Feb 27, 2019
0
28
In the Jan. 5, 2018 issue of Science, researchers from the University of Chicago Medicine show that specific strains of commensal bacteria - the swarms of microorganisms naturally dwelling in the intestines - can improve ...
Jan 4, 2018
2
313
Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment.
Oct 30, 2017
0
397
